Cargando…
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
BACKGROUND: COVID-19, which is a disease caused by the SARS-CoV-2 virus, has spread around the world since late 2019. Studies have found associations between the rising levels of TNF-α and severe COVID-19 cases. Hence, TNF-α blocking can possibly be a favorable intervention in modifying COVID-19. To...
Autores principales: | Fakharian, Atefeh, Barati, Saghar, Mirenayat, Maryam, Rezaei, Mitra, Haseli, Sara, Torkaman, Pooria, Yousefian, Sahar, Dastan, Alireza, jamaati, Hamidreza, Dastan, Farzaneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260560/ https://www.ncbi.nlm.nih.gov/pubmed/34426106 http://dx.doi.org/10.1016/j.intimp.2021.107961 |
Ejemplares similares
-
Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient
por: Fakharian, Atefeh, et al.
Publicado: (2022) -
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021) -
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023) -
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
por: Barati, Saghar, et al.
Publicado: (2021) -
Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
por: Yousefian, Sahar, et al.
Publicado: (2021)